MedTech Bioscience Conference Tackles a “Prescription for Change"
Friday, September 18, 2009
Syracuse, NY – One of the most high profile and debated initiatives the Obama administration has set out to accomplish is healthcare reform. Despite differences in opinion and whatever the result, these policy changes will result in significant challenges and opportunities for Upstate New York’s many bioscience companies. This is the premise behind MedTech’s annual bioscience industry conference onMonday, October 5, 2009 in Skaneateles Falls, NY.
Highlighting the rapid growth and deep resources in the bioscience industry in Upstate New York, more than 200 participants from bioscience companies, universities, service providers and economic developer are expected to attend the event. MedTech, the trade association for Upstate New York’s bioscience industry, is hosting the conference. Al DiRienzo of Blue Highway Inc. will explore issues in product development, especially innovative v. iterative change. In addition, Brian Bechard of InfiMed and Richard Paul of Hiscock & Barclay will share strategies and insights of selling overseas including cultural differences, logistical challenges, product adoption, and communications challenges. Nancy Nussmeier of Upstate Medical University will moderate a discussion around interactions between products companies and clinicians.
In addition, Julie Shimer of Welch Allyn will contribute to a CEO panel discussion with other regional leaders in the bioscience industry including Tom D’Ambra of Albany Molecular Research, Dan Kerpelman of BioOptonics, Joe Corasanti of ConMed, Tom Hook of Greatbatch, and Peter Robinson of University of Rochester Medical Center. This opening plenary panel will highlight trends, explore issues and feature current practices employed by six regional bioscience leaders.
"MedTech has made it a practice to bring exceptional national and regional thought-leaders together each fall,” said Heather Erickson, president of MedTech. “The MEDTECH 09 conference is by far our most impressive program to date. The wealth and depth of speaker expertise at this event is unmatched by any previous bioscience event in Upstate New York.”
Keynote speaker Mark Heller, partner of Goodwin Procter LLP in Washington, D.C., will discuss the Food and Drug Administration’s new leadership, possible legislative changes and emerging regulatory priorities. Marc Goloven, former senior regional economist at JPMorganChase, closes the annual conference with an economic analysis of the current environment and how it will influence opportunities for the industry.
The MEDTECH 09 conference will look at the future of the healthcare system from both a technology and a business perspective. Selected speakers in addition to DiRienzo, Bechard, Paul and Nussmeier include:
> Bela Musits; Managing Director, High Peaks Venture Partners
> Gary Pease; HR Director, Corning
> Gregory Jones; Vice President Regulatory Affairs and Quality Assurance, Linvatec
The conference will also include a Tech Showcase featuring new products, prototypes and promising research emerging from Upstate companies and universities. Exhibiting in the Tech Showcase is free for conference attendees. Registration information can be found at www.medtech.org/mt09.
For more information or for press credentials please contact Amy Porter (315) 423-7200 or email@example.com
MedTech is a not-for-profit trade association comprised of Upstate New York technology manufacturers, research institutions, and allied professional services and economic development organizations. We promote the commercialization of medical products by providing educational and networking events, organizing certification opportunities, and facilitating collaborations among members to bring tomorrow’s technologies to the health care marketplace. For more information, visit www.medtech.org.